Frankfurt, Germany and Raleigh, N.C., USA, October 6, 2017
Ms. Brinkley Chooses Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy® to Help Her Look Her Best
Merz announced today its partnership with supermodel, actress and entrepreneur, Christie Brinkley to help empower women to live, feel and look their best at any age by sharing tips she’s learned from maintaining her youthful appearance during her 45-year span in the beauty and fashion industries. Through this initiative, Ms. Brinkley, a mom, actress and entrepreneur, shares why she chose to have the lines between her brows treated with Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy®, the non-surgical skin tightening and lifting treatment, on her neck and décolletage to remain looking timeless and natural at age 63.
“I am vigilant about choosing products and treatments that help me to look as vibrant as I feel. When it comes to my body, I don’t compromise. Eating organic, exercising, practicing yoga and being active – it’s all part of staying healthy. I chose Xeomin®/Bocouture® (incobotulinumtoxinA) because it is highly purified, FDA-approved and clinically proven to temporarily smooth the lines between the brows,” stated Ms. Brinkley. “There are so many great non-invasive ways to give you the ‘perk’ that can help you look as good as you feel inside. That is why I am excited to work with Merz to help raise awareness that there are treatment options like Xeomin®/Bocouture®(incobotulinumtoxinA) and Ultherapy® available to adults of every age when they feel like they can use a little extra zing.”
Xeomin®/Bocouture® (incobotulinumtoxinA) is the most recently approved botulinum toxin type A by the Food and Drug Administration (FDA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients. Ultherapy® is the first and only treatment FDA-cleared to non-invasively lift the eyebrow, neck, and chin, and to improve lines and wrinkles on the décolletage. Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy® have not been studied or approved for combination use.
“Patients come to my practice to explore aesthetic medical options to help them look their best,” stated Dr. Patricia Wexler, a New York City-based dermatologist. “I appreciate that Christie is sharing her experiences with Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy®, letting people know that in-office treatments do not have to be intimidating and can help the world see them as they see themselves.”
According to a recent study, 83 percent of respondents had in-office procedures like Xeomin®/Bocouture®(incobotulinumtoxinA) or Ultherapy® to “look good for their age”. One out of three injectable patients say that they were motivated because of a particular moment in their lives. This can range from a “mirror moment” to a birthday or hearing about a friend’s or family member’s successful treatment.
“Christie is as iconic today as she was in her 20’s,” said Bob Rhatigan, CEO of Merz North America. “She is the perfect partner to help us educate consumers about Xeomin®/Bocouture® (incobotulinumtoxinA) and Ultherapy® because she shares our vision that adults of all ages should feel confident in how they present themselves to the world.”
As part of the partnership, Ms. Brinkley will share her overall beauty routine, including her tips for flawless skin, healthy hair, a strong body and a clean diet.
For more information visit http://www.xeomin.com/
www.global.ultherapy.com
https://www.merz.com/blog/news/christie-brinkley-partners-merz-share-approach-looking-timeless/